Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 551 - 600 out of 10,250

Document Document Title
WO/2009/135352A1
A plum tree extract comprises 0.5-50 wt% squalene The plum tree extract mainly comes from fat-soluble portion and/or water-soluble portion of non-fruit part of plum tree A method for preparing the plum tree extract, comprises using super...  
WO/2009/135918A1
The present invention provides a topical or therapeutic composition comprising a flavan-3-ol compound or a non-naturally occurring derivative thereof. The composition may for example be an anti-ageing composition or a composition for the...  
WO/2009/135311A1
An Echinozoa tissue or organ extract comprising antioxidant compounds is disclosed. Also disclosed is a process for obtaining an Echinozoa tissue or organ extract, as well as an extract obtained by this process. Compositions comprising s...  
WO/2009/135311A8
An Echinozoa tissue or organ extract comprising antioxidant compounds is disclosed. Also disclosed is a process for obtaining an Echinozoa tissue or organ extract, as well as an extract obtained by this process. Compositions comprising s...  
WO/2009/133647A1
Disclosed are: a method for covalently binding a cyclic nitroxide radical compound to a hydrophobic block in a specific hydrophilic-hydrophobic block copolymer; a polymerized cyclic nitroxide radical compound which is produced through th...  
WO/2009/133964A1
Disclosed is a novel agent for preventing oxidative stress. The agent for preventing oxidative stress comprises 4-(1-((4-methylbenzothiophen-3-yl)methyl)benzimidazol-2- ylthio)butanoic acid, 4-(1-((naphthalen-1- yl)methyl)benzimidazol-2...  
WO/2009/129592A1
An oral pharmaceutical liquid formulation comprising deferiprone and a taste masking composition, said taste masking composition comprising an effective amount of a sweetener (such as sucralose) per litre of liquid composition, an effect...  
WO/2009/129616A1
The invention provides methods of preventing or treating diseases or disorders caused by biological agents or chemical agents in a subject (e.g., a mammal, such as a human) by administering genetically modified human umbilical cord periv...  
WO/2009/130604A3
Provided herein are novel solid state forms of deferasirox salts, process for the preparation, pharmaceutical compositions, and method of treating thereof. The solid state forms of deferasirox salts are useful for preparing deferasirox (...  
WO/2009/130604A2
Provided herein are novel solid state forms of deferasirox salts, process for the preparation, pharmaceutical compositions, and method of treating thereof. The solid state forms of deferasirox salts are useful for preparing deferasirox (...  
WO/2009/127982A2
A method of synthesizing carboxylated amines is disclosed. The method comprises reacting a mixture of a potassium salt of either a primary or secondary amine with a potassium salt of a halogenated carboxylic acid wherein the halogenated ...  
WO/2009/128279A1
Disclosed is a composition for oral ingestion, which is useful for the prevention or treatment of hepatitis including NASH. Specifically disclosed is a composition for oral ingestion, which can be used for preventing or treating hepatiti...  
WO/2009/127982A3
A method of synthesizing carboxylated amines is disclosed. The method comprises reacting a mixture of a potassium salt of either a primary or secondary amine with a potassium salt of a halogenated carboxylic acid wherein the halogenated ...  
WO/2009/122337A1
The process for extracting active principles with antioxidant activity in particular polyphenols provides for extracting these principles from the leaves of the vegetable species of the Lippia polystachya of the family of the verbenaceae...  
WO/2009/110782A1
A composition comprising an extract from oil palm leaves characterized in that the extract comprises (-)-catechin gallate, ferulic acid, and phenolic acids such as gallic acid and protocatechuic acid and a method for producing said extra...  
WO/2009/108999A1
A method of inducing NAD+ synthesis in a subject. The method comprises administering to the subject a therapeutically effective amount of resveratrol or a functionally equivalent analogue or derivative thereof. NAD+ synthesis increases t...  
WO/2009/110495A1
Disclosed is a promoter for the secretion of insulin-like growth factor-1, which is safe, can be ingested on a daily basis, and comprises a polyphenol as an active ingredient. Also disclosed is a food or beverage containing the promoter....  
WO/2009/106368A1
The present invention relates to methods for increasing the activity of the immune system and, especially, to methods for increasing the activity of the immune system by modulation of endogenous ectophosphatase levels. According to a par...  
WO/2009/106850A1
An orally-administrable medicament for the treatment of damage to body tissues, particularly surface tissues, and especially tissues of the eye such as the retina and the corneal endothelium, comprises an anti-oxidant reagent. The anti-o...  
WO/2009/106773A2
The invention relates to a transgenic non-human mammal including an IgH locus modified by the replacement of the switching sequence Sμ with the totality or a portion of the transgene that comprises the gene Cγ of a G-class human immuno...  
WO/2009/103727A2
The invention relates to a combination comprising an iron chelator and an immunosuppressant, to the use of such combination for the improvement of immunosuppression, e.g. in hematopoietic stem cell transplantation.  
WO/2009/104661A1
Disclosed is an antioxidant agent in which the antioxidative activity of a noble metal microparticle contained therein is increased. The antioxidant agent comprises a noble metal microparticle as an active ingredient. The antioxidant age...  
WO/2009/103727A3
The invention relates to a combination comprising an iron chelator and an immunosuppressant, to the use of such combination for the improvement of immunosuppression, e.g. in hematopoietic stem cell transplantation.  
WO/2009/103950A1
Metal chelating compounds of formula (I) are provided: or tautomers thereof or a pharmaceutically acceptable salt of either characterised in that R1 is selected from the group H and C1-6 alkyl R2, R4 and R5 are independently selected fro...  
WO/2009/099679A3
The present invention is directed to compositions and methods of preserving viability of islets of Langerhans for transplantation, and treating various diseases and other abnormal or pathological conditions, including inflammatory bowel ...  
WO/2009/099679A2
The present invention is directed to compositions and methods of preserving viability of islets of Langerhans for transplantation, and treating various diseases and other abnormal or pathological conditions, including inflammatory bowel ...  
WO/2009/099132A1
Disclosed is a method for improving storage stability of glutathione in a solid composition containing glutathione and arginine. Also disclosed is a solid composition containing glutathione and arginine, which has improved storage stabil...  
WO/2009/097874A1
Disclosed are compositions comprising a combination of amino acids selected from: a) L-Cysteine with L-Methionine; b) L-Cysteine with L-Serine; c) L-Cysteine with L-Methionine and L-Serine; d) L-Methionine with L-Serine; or precursors or...  
WO/2009/099222A1
Disclosed is a process for producing a composition having a high polyphenol content, particularly a composition having a high cacao polyphenol content and a low theobromine content in a simple manner and with high efficiency. The process...  
WO/2009/099220A1
Disclosed is a process for producing a composition having a high polyphenol content, particularly a composition having a high cacao polyphenol content and a low theobromine content in a simple manner and with high efficiency. The process...  
WO/2009/096579A1
Disclosed is a nutritional composition for preventing hyperglycemia, which comprises a nitrogen source, a lipid and a sugar component, wherein the nitrogen source comprises free isoleucine and/or free leucine, the lipid comprises a middl...  
WO/2009/095615A2
The subject matter of the invention is the use of at least one active ingredient derived from Cyperus esculentus in or for the preparation of a cosmetic and/or dermopharmaceutical composition for combating skin ageing, preferably by acti...  
WO/2009/096905A1
There is presently provided methods for delivering an anti-fibrotic or anti-cancer agent to a cell. The methods comprise contacting a cell with an effective amount of imidazolium and imidazolinium compounds as described herein, including...  
WO/2009/092323A1
Provided are uses of PDCD5 polypeptide or polynucleotide encoding it for preparing tumor chemo-sensitizer and protecting normal or diseased tissues and organs from injury or further damage. Drug combinations comprising chemotherapeutic d...  
WO/2009/087988A1
Provided is a composition for reducing oxidative stress and/or side effects occurring during cancer chemotherapy or improving nutritional status during cancer chemotherapy. The composition is a composition for reducing oxidative stress a...  
WO/2009/084612A1
Disclosed is a method for producing an eriocitrin-containing material, which comprises the steps of: extracting a citrus extract containing eriocitrin from a citrus fruit with an extraction solvent; and separating eriocitrin from the cit...  
WO/2009/084482A1
Disclosed is a means for promoting the absorption of a sesamin component in the body. The absorption of a sesamin component in the body can be promoted by using the sesamin component in combination with a quercetin glycoside.  
WO/2009/084743A1
An external preparation containing an active hydrogen-generating agent which generates active hydrogen in the case of bringing a plural number of agents into contact with each other and/or an active hydrogen-generating agent which activa...  
WO/2009/078366A1
Disclosed is a stable α-lipoic acid. Also disclosed is a method for producing α-lipoic acid nanoparticles, which comprises a step of preparing an aqueous dispersion liquid containing α-lipoic acid and a nonionic surfactant; a step of ...  
WO/2009/078474A1
The present invention provides an agent for reducing a side effect of an anticancer drug, which comprises a thrombin-like enzyme.  
WO/2009/076506A3
The present invention concerns the γ-glutamylcysteine treatment to reduce oxidative damage caused by ischemia/reperfusion events such as pulmonary hypertension, transplant, cardiac bypass and other surgeries, and trauma. In specific emb...  
WO/2009/075573A1
The present invention relates to a liquid nutritional composition for paediatric patients comprising beta-galacto-oligosaccharides, fructan, non-digestible alpha-glucan and hemicellulose.  
WO/2009/075564A1
The present invention relates to a liquid nutritional composition for paediatric patients comprising beta -galacto -oligosaccharides, fructan, non -digestible alpha -glucan and hemicellulose.  
WO/2009/072004A2
The present invention relates to methods for decreasing cellular DNA repair in a target patient; decreasing cellular NAD+ biosynthesis in a target patient; increasing efficiency of radiation therapy in a target patient; modulating nicoti...  
WO/2009/072004A3
The present invention relates to methods for decreasing cellular DNA repair in a target patient; decreasing cellular NAD+ biosynthesis in a target patient; increasing efficiency of radiation therapy in a target patient; modulating nicoti...  
WO/2009/069736A1
Disclosed is a nitrogenated compound represented by the formula (I) [wherein A represents an aryl which may have a substituent or the like; B's independently represent a hydrogen atom, a halogen or the like; n represents an integer of no...  
WO/2009/068798A1
The invention relates to a composition for protecting and/or preserving cells, tissues and organs, characterised in that it includes at least one modified positively-charged cyclodextrin preferably closely associated with an anti-oxidant...  
WO/2009/064004A1
It has been required to develop a drink which contains citrulline, generates little offensive odor when stored or heated and is easy to drink. Thus, a drink containing citrulline together with citric acid, sodium citrate or disodium hydr...  
WO/2009/055863A1
The present invention relates to desferoxamine conjugates, derivatives and analogues thereof. In particular, the present invention relates to desferoxamine conjugates, analogues and derivatives thereof, and methods for reducing levels of...  
WO/2009/053637A2
The subject of the present invention is an anti-ricin antibody and the use thereof for the treatment of an individual suffering from ricin poisoning.  

Matches 551 - 600 out of 10,250